Livdelzi 10 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DR26FKJG0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,733
Award facts
- Contract value 100% obligated
- $9,732.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $9,732.57 to DMS Pharmaceutical Group Inc. for LIVDELZI 10 mg capsules (30-count supply) with an ultimate completion date of November 18, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which carries a $499.999 billion ceiling value and extends through December 31, 2036.
The PPV-G GEN V represents part of the broader $30.3 billion Defense Logistics Agency pharmaceutical acquisition strategy designed to provide recurring medical supply support to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's extensive product portfolio includes branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals, positioning the company as a critical supplier within the federal military medical supply chain. The company's established performance on numerous delivery orders across multiple therapeutic categories demonstrates its operational capability to fulfill the diverse pharmaceutical requirements of the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DR26FKJG0?
SPE2DR26FKJG0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DR26FKJG0 worth?
The government has obligated $9,733 on SPE2DR26FKJG0.
Is contract SPE2DR26FKJG0 an order under another contract?
Yes. SPE2DR26FKJG0 is a delivery order under SPE2DR25D9105, an indefinite delivery contract.
Was contract SPE2DR26FKJG0 competed?
The extent of competition for SPE2DR26FKJG0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award